Alkermes’ Corporate Presentation to be Webcast at the NASDAQ OMX 27th Investor Program

DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the NASDAQ OMX 27th Investor Program on Tuesday, December 6, 2011, at 1:15 p.m. GMT (8:15 a.m. ET) from the Chancery Court Hotel in London. The presentation may be accessed from the investor relations section on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio. For more information, please visit Alkermes’ website at


Alkermes plc
Eva Stroynowski, +1-781-609-6823
Corporate Communications

KEYWORDS:   United Kingdom  United States  Europe  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Professional Services  Banking  Finance